Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance

  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Lyophilized Methylprednisolone Sodium Succinate 1g
  Indications :
 

Neurological Conditions :
Multiple Sclerosis, Spinal Cord Injury, Cerebral injury

Nephrological Conditions :
Glomerular nephritis and Lupus nephritis

Organ Transplant :

Acute Respiratory Distress Syndrome (ARDS)

   
  Dosage :
  In Multiple Sclerosis
1g/day I.V. for 3-5 days.

In Optic Neuritis
1g/day I.V. for 3 days followed by oral prednisolone therapy.

In Renal transplantation
a ) For induction of Immunosuppression : Start with 80-160 mg OD for three days followed by oral therapy.
b ) In treatment of acute rejection: 500 mg upon diagnosis, followed by 500 mg OD for two days.

Oedematous states
30 mg/kg body weight every other day for 4 days or 1gm /day for 3, 5 or 7 days I.V.

Acute Spinal cord injury
30 mg /kg bolus followed by 5.4 mg/kg bolus for 24-48 hours.

Prevention of ARDS and Fat Embolism syndrome
30 mg /kg body weight can be repeated after 6 hours.
   
  Packing : 1 Vial of 1g
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.